# OnCo record paper-luca-gianni-j-clin-oncol-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-luca-gianni-j-clin-oncol-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-luca-gianni-j-clin-oncol-2022" ;
  schema:name "Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study"@en ;
  schema:description "Paper by Luca Gianni indexed on Europe PMC as PubMed record 34890214, in Journal of Clinical Oncology (2022), one of the most cited records naming an author with this name at Fondazione Michelangelo."@en ;
  schema:url <https://onco.cc/key-papers/paper-luca-gianni-j-clin-oncol-2022/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.21.00896>, <https://pubmed.ncbi.nlm.nih.gov/34890214/>, <https://europepmc.org/article/MED/34890214> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.21.00896> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Krop IE, Im SA, Barrios C, et al." ;
  onco:people <https://onco.cc/people/luca-gianni/> ;
  onco:journals <https://onco.cc/journals/jco/> .